• Business
  • Entertainment
  • Health
  • News
  • Sport
  • Tech
  • World
Newsy Today
news of today
Home - patients
Tag:

patients

Health

Nurse Fired After Video Claims She Avoids Fox News Viewers

by Chief Editor July 5, 2026
written by Chief Editor

UTMB fired a contract nurse following a viral video that suggested she would avoid treating patients who watch Fox News. The University of Texas Medical Branch confirmed the termination on July 3, 2026, stating the employee’s actions contradicted the institution’s commitment to providing unbiased, compassionate care to every patient.

What triggered the UTMB investigation?

The investigation began after a video featuring a nurse, identified online as “Nurse Ahlam,” went viral on social media. In the clip, the nurse appeared to back out of a patient’s room while the song “I Will Always Love You” by Whitney Houston played in the background. The video included a caption stating, “When I walk into my patient’s room and Fox News is blasting.”

The controversy escalated when the eight-second clip was reposted by the account Libs of TikTok on X. The post reached hundreds of thousands of viewers, leading to widespread accusations that the nurse was violating the ethical responsibility to provide care without discrimination. According to UTMB, the university learned of the posts on a Thursday afternoon and concluded its investigation by terminating the employee’s contract that same evening.

Did you know?

Medical ethics codes generally mandate that healthcare decisions must be based solely on a patient’s clinical needs. Professional organizations emphasize that personal or political beliefs should not influence the quality or availability of treatment.

How does social media impact professional medical ethics?

This incident highlights a growing trend where social media serves as a real-time oversight mechanism for professional conduct. While the nurse’s post was interpreted by some as political satire, the public reaction centered on the perceived threat to impartial medical treatment. Users on social media argued the video undermined the fundamental trust between patients and healthcare providers.

As digital footprints become more permanent, healthcare institutions are increasingly forced to address how personal social media content intersects with professional standards. The speed of the UTMB response—moving from discovery to termination within a single afternoon—suggests that medical employers are prioritizing rapid reputational and ethical management in response to viral content.

What are the standards for unbiased patient care?

Medical professionals are bound by ethical standards that require care to be provided regardless of a patient’s identity or personal views. These standards include, but are not limited to, political affiliations, religious beliefs, and lifestyle choices. When a healthcare worker’s public behavior suggests a bias, it can trigger internal reviews regarding their ability to fulfill these duties.

Doctor resigns over Charlie Kirk controversy #shorts #charliekirk #usnews #foxnews #us

The core of medical ethics relies on the principle that treatment decisions must remain clinical. According to professional guidelines, any indication that a provider might withhold or alter care based on a patient’s personal media consumption or political leanings is viewed as a violation of the duty of care.

Pro Tip for Healthcare Professionals:

Maintaining a clear distinction between personal political expression and professional identity is critical. Many healthcare institutions now include social media conduct clauses in employment contracts to mitigate risks associated with viral content.

Frequently Asked Questions

Why was the nurse at UTMB terminated?

UTMB stated the employee was fired because her social media behavior was inconsistent with the university’s values and its commitment to providing unbiased, compassionate care to all patients.

How did the video go viral?

The video gained significant traction after it was reposted by the Libs of TikTok account on the platform X, where it garnered hundreds of thousands of views.

Do nurses have the right to express political views online?

While individuals have personal rights to expression, healthcare professionals are held to ethical standards that prohibit behavior—online or offline—that suggests discriminatory treatment of patients based on their beliefs or affiliations.

What do you think about the intersection of social media and professional ethics? Share your thoughts in the comments below or subscribe to our newsletter for more industry updates.

July 5, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Oral Wegovy: A Doctor’s Honest Review

by Chief Editor June 21, 2026
written by Chief Editor

The FDA’s approval of the Wegovy oral semaglutide pill in late December 2025 offers a needle-free weight management option, though it requires more rigorous dosing than the injectable version. According to Dr. Anthony Puopolo, Chief Medical Officer at LifeMD, the pill delivers the same molecule as the shot but faces biological barriers that demand strict adherence to a specific morning routine.

Is the Wegovy pill safer than the Wegovy injection?

Many patients assume a pill is a gentler alternative to a weekly injection, but clinical data suggests otherwise. Dr. Anthony Puopolo, a board-certified family medicine physician, states that the assumption that oral semaglutide is safer or gentler is “dangerous.”

While the pill and the injection deliver the same molecule to the same receptors, the oral route presents different challenges. Dr. Puopolo notes that the pill may actually cause slightly more gastrointestinal side effects than the injectable form. Both versions carry the same systemic risks, as the underlying medication remains identical once it enters the bloodstream.

“The pill and injection deliver the same molecule to the same receptors with the same effects,” says Dr. Puopolo. “But the oral route requires pharmaceutical engineering to overcome fundamental biological barriers.”

Did you know? Unlike the injectable version, the Wegovy pill does not require refrigeration, making it a more practical option for frequent travelers.

How do you take oral semaglutide correctly?

The primary difference between the two formats is the logistical commitment required by the patient. To ensure the drug is absorbed effectively, the Wegovy pill requires a strict daily protocol that many patients may find difficult to maintain.

Patients must take the pill once daily on an empty stomach with a small amount of plain water. Following ingestion, a 30-minute waiting period is required before consuming any food or other medications. Dr. Puopolo explains that these requirements aren’t “arbitrary pharmaceutical fussiness” but are biologically necessary for the drug to work.

Comparison of Administration Requirements

Feature Wegovy Injection Wegovy Pill
Frequency Weekly Daily
Food Restriction Minimal 30-minute empty stomach
Storage Often requires refrigeration Room temperature

Will the Wegovy pill cause muscle loss?

Muscle preservation remains a critical concern for anyone using GLP-1 medications. Because both the pill and the injection create a similar caloric deficit, the risk of muscle loss is identical for both formulations.

Oral semaglutide approved by FDA for obesity treatment

Dr. Puopolo clarifies that there is no biological reason to expect the pill to be better or worse for maintaining muscle mass. To mitigate this risk, medical experts recommend two primary strategies regardless of the delivery method: consistent resistance training and high protein intake.

Pro Tip: To maximize the value of semaglutide, prioritize protein-rich foods and strength training to ensure weight loss comes primarily from fat rather than lean muscle tissue.

How much does the Wegovy pill cost compared to the shot?

The financial impact of switching to the pill depends heavily on how a patient pays for their medication. For patients paying entirely out-of-pocket, the oral formulation is generally less expensive than the injection.

However, for those with insurance coverage, Dr. Puopolo notes that the out-of-pocket difference is often minimal. He suggests that the most significant “cost” to a patient isn’t the price of the pill itself, but rather the ability to maintain long-term adherence and implement necessary lifestyle changes.

Can patients switch from injections to the pill?

Switching from an injectable to an oral version is a clinical decision that should not be made casually. While Dr. Puopolo describes the transition as “clinically reasonable” for motivated patients, he warns of potential setbacks during the adjustment period.

Patients switching formats may experience transient gastrointestinal side effects. There is also a potential risk of a temporary gap in efficacy while the body adjusts to the new delivery method. Patients should consult their healthcare provider to manage this transition safely.

Frequently Asked Questions

Can I take the Wegovy pill with my morning coffee?

No. The pill should be taken with a small amount of plain water, and you must wait roughly 30 minutes before consuming anything else, including coffee.

Is the pill more effective for weight loss than the shot?

No. Both formulations deliver the same semaglutide molecule and are expected to produce similar weight management results.

Who is the best candidate for the Wegovy pill?

The pill is ideal for needle-averse patients and those who travel frequently, provided they can strictly follow the daily dosing protocol.

Have questions about your medication options? Share your thoughts in the comments below or subscribe to our newsletter for the latest health updates.

June 21, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Ozempic Pill vs. Shot: A Doctor’s Honest Comparison

by Chief Editor May 28, 2026
written by Chief Editor

Beyond the Needle: The Future of Weight Management and the Oral Semaglutide Shift

The landscape of metabolic health is shifting beneath our feet. With the FDA’s approval of oral semaglutide, the conversation has moved from “Can I lose weight?” to “How do I maintain this safely for the long haul?” As an industry observer who has tracked the rise of GLP-1 agonists, I’ve seen the hype—but the reality is more nuanced than a simple pill-versus-shot debate.

The Evolution of Delivery Systems

While the oral version of semaglutide is a milestone in pharmaceutical engineering, it isn’t a “lighter” version of the medication. It is the same potent molecule, just packaged differently to survive the treacherous journey through your stomach acid. The future of this field isn’t necessarily about choosing a pill over a shot. it’s about personalized delivery systems.

Did You Know?

Oral semaglutide requires specific absorption conditions—typically an empty stomach and a precise window of time without other food or liquids. This “biological tax” is the primary reason why some patients actually find the weekly injection more convenient, despite the needle.

View this post on Instagram about Ozempic Pill, Doctor Honest Comparison
From Instagram — related to Ozempic Pill, Doctor Honest Comparison

The “Muscle-First” Approach to Weight Loss

One of the most persistent myths in the obesity treatment space is that the medication does the work for you. Whether you choose an oral or injectable format, the biological outcome remains the same: a significant caloric deficit. Without intervention, this leads to the loss of both fat and metabolically active muscle tissue.

Looking ahead, the gold standard of care will move toward muscle-sparing protocols. Data consistently shows that patients who combine GLP-1 therapy with resistance training and a high-protein diet (aiming for 1.2g to 1.5g of protein per kilogram of body weight) maintain significantly better metabolic health than those who rely solely on the drug.

Pro Tip: The Protein Baseline

Don’t wait until you start losing weight to prioritize protein. Start your intake goal before your first dose. Aiming for 25–30 grams of protein at each meal is a simple, actionable way to signal to your body that it needs to hold onto its muscle mass.

Semaglutide For Weight Loss: Injections vs Oral

Predicting the Next Wave of Metabolic Treatments

As we look toward the next five years, expect to see “combination therapy” become the buzzword in clinical settings. We are moving toward a future where drugs are paired with digital health platforms. The goal is to maximize the “drug-lifestyle synergy,” where app-based tracking and remote monitoring ensure the patient is hitting their nutritional targets while on the medication.

Frequently Asked Questions

Is the pill less effective than the injection?

Not necessarily. Once the molecule is absorbed, it works the same way. However, the pill requires strict adherence to dosing instructions to ensure the correct amount reaches your bloodstream.

Should I switch from shots to pills?

Only if your doctor agrees. Switching can lead to a “gap” in efficacy or a resurgence of side effects as your body adjusts to a different absorption profile.

Does insurance cover the pill differently?

Often, yes. While out-of-pocket costs for the pill may be lower, insurance coverage varies wildly. Always check your formulary before assuming it will be cheaper.

The Bottom Line

The future of weight management isn’t found in a magic pill or a miracle shot—it’s found in the consistency of your habits. Whether you opt for an oral medication or an injection, the “work” remains the same: resistance training, protein optimization, and long-term metabolic monitoring.

Want to stay ahead of the curve?

Subscribe to our weekly health newsletter for the latest updates on metabolic science and nutrition trends.

May 28, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Generic semaglutide to hit Canadian pharmacies this week at a fraction of the cost of Ozempic

by Chief Editor May 21, 2026
written by Chief Editor

The Price Drop: How Generics Are Changing the GLP-1 Landscape

For years, semaglutide—the active ingredient in brand-name drugs like Ozempic and Wegovy—has been whispered about in celebrity circles and sought after in clinics across Canada. But for many, the “miracle drug” came with a prohibitive price tag, often ranging from $200 to over $450 per month depending on the province.

That narrative is shifting. With the arrival of generic versions from manufacturers like Apotex, and Dr. Reddy’s, we are entering a new era of “democratized” metabolic health. When a drug moves from a monopoly to a competitive generic market, the impact isn’t just financial; it’s clinical. More patients can maintain their treatment plans without the stress of “sticker shock” at the pharmacy counter.

Did you know? Canada has become one of the first G7 nations to approve a generic version of semaglutide, signaling a proactive approach to lowering the cost of chronic disease management.

The financial shift is stark. While brand-name options have historically been expensive, some generic entries are hitting the market at a fraction of the cost—with some providers offering semaglutide for as low as $150 a month. According to the pan-Canadian Pharmaceutical Alliance, the entry of two generic competitors typically drives prices down by at least 50% compared to the brand name.

Beyond the Brand: What the “Generic Shift” Means for Patients

The transition to generics often triggers a wave of anxiety regarding efficacy. Patients wonder: Is the cheaper version as effective? From a regulatory standpoint, the answer is a resounding yes. Health Canada employs a rigorous review process to ensure that generic medications are chemically as close to the original as possible.

Beyond the Brand: What the "Generic Shift" Means for Patients
Health Canada approval logo with semaglutide

However, the real trend to watch is the “off-label” divide. While semaglutide is officially approved for Type 2 diabetes, its use for weight loss has exploded. Historically, public drug plans have been hesitant to cover “off-label” weight loss, leaving thousands to pay out of pocket. As generics lower the cost, the barrier to entry for obesity treatment drops, potentially reducing long-term healthcare costs associated with obesity-related comorbidities.

The Battle for the Wallet: Novo Nordisk vs. The Newcomers

The entry of generics forces the original patent holder, Novo Nordisk, to evolve. We are already seeing the industry respond with “savings programs” and strategic pricing adjustments to keep patients loyal to the brand name. This “price war” is a win for the consumer, as it creates a market where the patient—not the manufacturer—holds the leverage.

Cheaper Ozempic alternative set to launch in Canada

As more submissions for generic semaglutide undergo review, we can expect a “race to the bottom” in terms of pricing, making these life-altering medications accessible to a much broader demographic of the Canadian population.

Pro Tip: Your pharmacist is your best ally in this transition. They can navigate the complex world of provincial substitution rules and help you determine if your insurance plan will cover the generic switch or if you’ll save more by paying out of pocket.

Navigating the New Pharmacy Reality

The rollout of generic GLP-1s isn’t instantaneous. Because these drugs move through a complex supply chain involving distributors and thousands of individual pharmacies, availability may vary by region. Major chains like Shoppers Drug Mart and Rexall are integrating these stocks, but the “last mile” of delivery can take time.

For those currently on brand-name Ozempic, the transition involves a few key steps:

  • Consult your physician: Ensure a generic substitution is clinically appropriate for your specific health profile.
  • Check your formulary: Private insurance and provincial plans update their “approved” lists at different speeds. A generic might be available at the pharmacy before your insurance agrees to pay for it.
  • Verify the manufacturer: With multiple generics entering the market, different brands (like Apotex or Dr. Reddy’s) may have different availability levels.

For further reading on how to manage prescription costs, check out our guide on Navigating Canadian Drug Insurance.

Frequently Asked Questions

Are generic semaglutide drugs safe?
Yes. Generic drugs approved by Health Canada must meet the same rigorous standards for safety, quality, and efficacy as the brand-name version.

Frequently Asked Questions
Ozempic vs generic pills side

Will my insurance cover the generic version?
It depends on your provider. Public and private insurers determine their own formularies. Some may require the generic version to be used before they will pay for the brand name.

Can I switch from Ozempic to a generic without a new prescription?
In many provinces, pharmacists can substitute a generic for a brand-name drug unless the doctor has specifically written “no substitution” on the prescription.

Why is there a price difference between different generics?
Pricing is determined by the manufacturer’s production costs and their competitive strategy. Some aim for high-volume, low-cost market penetration, while others may price more conservatively.

Join the Conversation

Are you considering the switch to generic semaglutide, or have you already seen the price difference at your local pharmacy? Share your experience in the comments below or subscribe to our newsletter for the latest updates on healthcare affordability in Canada.

Subscribe for Health Updates

May 21, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Patients say they want Alzheimer’s blood tests. Doctors aren’t sure they help.

by Chief Editor April 29, 2026
written by Chief Editor

The Alzheimer’s Blood Test Dilemma: Hope, Hype, and What It Means for You

The promise is compelling: a simple blood test, administered even before symptoms appear, could reveal your future risk of developing Alzheimer’s disease. But as these tests become more readily available, a crucial question arises – should you acquire tested, and what would you do with the information? The landscape is complex, filled with ongoing debate about accuracy, predictive power, and the psychological impact of knowing.

Unlocking the Brain’s Secrets: Amyloid and Tau as Biomarkers

Most Alzheimer’s blood tests focus on measuring levels of amyloid and tau proteins. These proteins accumulate in the brain years, even decades, before cognitive decline becomes noticeable. Even as their presence is a hallmark of the disease, the relationship isn’t straightforward. The tests aim to detect changes in these proteins that may indicate an increased risk, but doctors emphasize that a positive result doesn’t guarantee a future diagnosis.

View this post on Instagram about Unlocking the Brain, Amyloid and Tau
From Instagram — related to Unlocking the Brain, Amyloid and Tau

The Accuracy Question: Predicting the Unpredictable

A key concern is the predictive accuracy of these tests. Some individuals who test positive for elevated amyloid or tau levels never develop Alzheimer’s, raising questions about their reliability. Experts caution against relying solely on blood test results, emphasizing the need for comprehensive evaluation. A 2024 study found blood tests correctly identified Alzheimer’s in patients with memory problems approximately 90% of the time, but this research was conducted in Sweden and requires validation in more diverse populations.

Pro Tip: Blood tests are often used as a screening tool to determine if further, more definitive testing – like PET scans or spinal fluid analysis – is warranted.

The FDA’s Stance and Current Approvals

Currently, the Food and Drug Administration (FDA) has cleared two blood tests for Alzheimer’s, but only for individuals already exhibiting symptoms. These tests are not intended for widespread screening of asymptomatic individuals. The FDA highlights the risk of inaccurate results – both false positives and false negatives – which could lead to inappropriate diagnoses and treatment decisions.

The FDA’s Stance and Current Approvals
Knowing Stance and Current Approvals Currently Food Drug

Beyond Diagnosis: Tracking Treatment and Future Possibilities

Neurologists envision several potential uses for these blood tests beyond initial diagnosis. They could be used to monitor the effectiveness of treatments, tracking changes in amyloid or tau levels over time as a patient undergoes therapy. Researchers hope that future iterations of these tests could serve as a standalone diagnostic tool, eliminating the need for more invasive and expensive procedures.

The Psychological Impact: Knowing vs. Not Knowing

Even with improved accuracy, the psychological implications of receiving a positive result remain significant. A recent survey published in Alzheimer’s & Dementia revealed that 85% of patients would take a blood test if recommended by their doctor, but nearly 75% anticipated feeling distressed by a positive result. This highlights the anxiety surrounding the disease and the potential emotional burden of knowing one’s future risk.

Alzheimer's Association says some blood tests can be used to diagnose the disease

Limited Treatment Options: A Crucial Consideration

Currently, there is no cure for Alzheimer’s disease, affecting approximately 7 million people in the U.S., according to the Mayo Clinic. The two FDA-approved drugs, Leqembi and Kisunla, aim to slow the progression of the disease, but their efficacy is debated, and they carry potential side effects like brain swelling and bleeding. Lifestyle factors, such as diet and exercise, may help reduce risk, but their impact is limited.

The Role of the Alzheimer’s Association

The Alzheimer’s Association advocates for increased access to testing, emphasizing the simplicity, affordability, and convenience of blood tests compared to PET scans or MRIs. They believe that early diagnosis empowers individuals to plan for the future and participate in clinical trials. However, they also acknowledge the need for ongoing research to improve test accuracy and address the psychological impact of results.

The Role of the Alzheimer’s Association
The Psychological Impact Knowing

What Does This Mean for You?

The development of Alzheimer’s blood tests represents a significant step forward in the fight against this devastating disease. However, it’s crucial to approach these tests with realistic expectations and a clear understanding of their limitations. Discuss the potential benefits and risks with your doctor before considering testing, and remember that a blood test is just one piece of the puzzle.

Frequently Asked Questions

  • Are Alzheimer’s blood tests widely available? Currently, availability is increasing, but access may vary depending on your location and healthcare provider.
  • How much do these tests cost? The cost can vary, but they are generally less expensive than PET scans or MRIs.
  • What if I get a positive result? A positive result doesn’t mean you will definitely develop Alzheimer’s. Further evaluation and discussion with your doctor are essential.
  • Can these tests prevent Alzheimer’s? Currently, there is no way to prevent Alzheimer’s, but early detection may allow for interventions to slow its progression.

Want to learn more? Explore additional resources on the Alzheimer’s Association website and discuss your concerns with your healthcare provider.

April 29, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

The right way to stop taking Ozempic, Wegovy, or Mounjaro, according to doctors

by Chief Editor April 23, 2026
written by Chief Editor

Beyond the Scale: The Long-Term Reality of GLP-1s

For many, medications like Ozempic, Wegovy, and Mounjaro have felt like a miracle for weight management. However, a critical shift is occurring in how medical experts view these tools. Rather than seeing them as short-term solutions, the trend is moving toward treating GLP-1s as long-term interventions.

View this post on Instagram about Type, Stopping
From Instagram — related to Type, Stopping

The complexity arises when patients decide to quit. Whether driven by cost, insurance barriers, or the desire to avoid a lifelong commitment, stopping these medications is rarely as simple as just missing a dose. For some, the cost is a primary driver, with drugs typically costing more than $1,000 per month without insurance.

Did you grasp? Research indicates high discontinuation rates for GLP-1s, ranging from 36% to 81% within the first year for those with Type 2 diabetes, and 65% within one year for those without diabetes.

The “Rebound” Effect: What Happens When the Medication Stops

When a patient stops a GLP-1 medication, the biological changes happen quickly. The most immediate impact is the return of “food noise”—the persistent cravings and hunger that the medication previously suppressed.

The "Rebound" Effect: What Happens When the Medication Stops
Type Tapering Stopping

This happens since the body loses the signals that suppress appetite, and the stomach no longer slows down the movement of food, meaning patients no longer feel full as quickly. But the impact extends far beyond hunger.

Cardiovascular and Metabolic Risks

One of the most significant emerging concerns is the impact on heart health. While sustained employ is associated with a reduced risk of heart attack and stroke, discontinuing the therapy can reverse these benefits.

Data from a study of 330,000 Veterans Affairs patients with Type 2 diabetes highlighted a stark contrast: those who used GLP-1 medications steadily over three years saw an 18% reduced risk for heart attacks, and strokes. Conversely, those who stopped the medication for two years saw their risk rise by 22%.

Other metabolic shifts often include a rise in blood sugar levels, increased blood pressure, and higher cholesterol levels. In some cases, blood sugar increases and diabetes symptoms worsen within 16 weeks of stopping medications like Tirzepatide.

Strategic Off-Ramping: Tapering vs. Cold Turkey

Because GLP-1 medications are not addictive, stopping “cold turkey” is medically safe. However, many physicians now lean toward a gradual taper for practical reasons.

How to Stop Taking Things Personally

Tapering provides a window for patients to optimize lifestyle changes, which helps avoid the rapid weight regain that often accompanies an abrupt stop. The goal is to transition the body from pharmacological support to behavioral maintenance.

Pro Tip: To mitigate weight regain, establish a high-protein, high-fiber diet and incorporate strength training at least twice a week before you initiate the process of stopping your medication.

Building a Safety Net for Weight Maintenance

Stopping a GLP-1 without a comprehensive plan is often compared to taking off a cast before a bone has fully healed. To maintain results, a multidisciplinary approach is essential.

Building a Safety Net for Weight Maintenance
Tapering Stopping Safety Net for Weight Maintenance Stopping

Successful maintenance typically involves a team that may include a doctor, dietitian, health coach, and therapist. This ensures that weight loss is approached from both a physical and mental perspective.

Key pillars for a post-medication plan include:

  • Nutritional Shift: Developing a taste for meals high in fiber and protein while reducing refined carbohydrates.
  • Physical Activity: Consistent exercise with a focus on lean muscle preservation to counter the severe loss of lean muscle that can sometimes lead doctors to recommend stopping the medication.
  • Clinical Monitoring: Following up with a doctor within four to six weeks of stopping, as this is when appetite changes typically resurface.

Common Questions About Stopping GLP-1s

Is it safe to stop GLP-1 medications abruptly?
Yes, it is medically safe because these medications are not addictive, while tapering may be preferred to manage weight regain and lifestyle transitions.

Will I gain the weight back if I stop?
There is a high possibility of regaining lost weight if healthy lifestyle habits are not established and maintained after discontinuation.

Why do some doctors recommend stopping these drugs?
Doctors may advise discontinuation if risks outweigh benefits, such as in cases of pregnancy, pancreatitis, malnutrition, or severe loss of lean muscle.

What are the most common side effects that lead people to quit?
The most common reasons include nausea, diarrhea, vomiting, constipation, and abdominal pain.

For more insights on metabolic health and long-term wellness, explore our latest health guides or consult with a board-certified obesity medicine specialist.

Are you navigating the transition off GLP-1 medications?

Share your experience in the comments below or subscribe to our newsletter for more expert-backed health strategies.

April 23, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Is ‘Perimenopause’ the New Women’s Health Epidemic—or Misinformation?

by Chief Editor March 26, 2026
written by Chief Editor

The Rising Tide of Perimenopause Awareness: A Critical Look at Medicalization and the Future of Women’s Health

A new film, “The M Factor 2: Before the Pause,” premiering on PBS, is sparking debate about the increasing medicalization of perimenopause. Following its predecessor, “The M Factor,” this sequel focuses on the often-overlooked transition that can start in a woman’s 30s and last for a decade. But is this increased attention empowering, or is it fueling unnecessary anxiety and a booming industry built on treating a natural life stage?

From Menopause to Perimenopause: Expanding the Definition of “Illness”?

The core concern raised by critics is the broadening definition of what constitutes a medical problem. While menopause – the cessation of menstruation – is a clearly defined biological event, perimenopause is far more ambiguous. The National Institutes of Health concluded in 2005 that only vasomotor symptoms (hot flashes and night sweats), vaginal dryness, and potentially sleep disturbances are definitively linked to menopause. Attributing a wider range of symptoms – from weight gain and “brain fog” to general feelings of being “not myself” – to perimenopause is, according to some experts, a misdiagnosis of normal aging and life stressors.

This trend is amplified by influencers, advocates, and doctors who often simultaneously promote products or services aimed at alleviating perimenopausal symptoms. The film itself offers merchandise with slogans like “I’m just not feeling like myself,” raising questions about potential conflicts of interest.

A Historical Echo: Controlling Women Through Hormones

The current focus on perimenopause isn’t entirely new. Historically, women’s bodies and behaviors have been pathologized and “treated” through hormonal manipulation. In the early 20th century, thousands of women underwent oophorectomies (removal of the ovaries) to address conditions like “troublesomeness” or even “erotic tendencies.” This historical context highlights a concerning pattern of attempting to control women’s experiences through medical intervention.

The idea that women are inherently unstable due to their hormones is a long-standing trope. The current narrative risks reinforcing this idea, suggesting that women need to be “fixed” rather than supported through a natural transition.

The Perimenopause Industry: A Booming Market

The increased awareness of perimenopause has fueled a rapidly growing market for supplements, apps, therapies, and hormone replacement treatments. While some women genuinely benefit from these interventions, the potential for overdiagnosis and unnecessary treatment is significant. A recent report highlighted the booming business surrounding perimenopause, with companies capitalizing on women’s anxieties and offering solutions that may not be evidence-based.

The case of Jessica Toonkel, a Wall Street Journal journalist, serves as a cautionary tale. Her persistent itchiness was initially attributed to perimenopause by her doctors, but was ultimately diagnosed as cancer. This underscores the danger of attributing all symptoms to hormonal changes and delaying proper investigation.

Beyond Hormones: A Holistic Approach to Midlife

Research suggests that many symptoms attributed to perimenopause are also experienced by men during midlife, including forgetfulness, decreased sexual desire, and increased waist circumference. This suggests that these symptoms may be more closely linked to aging and lifestyle factors than to hormonal fluctuations alone.

Experts advocate for a more holistic approach to women’s midlife health, emphasizing healthful eating, exercise, mental health support, and strong community connections. The empowerment model for menopause, as highlighted by The Lancet, focuses on supporting women through this transition rather than attempting to “cure” it.

What Does the Future Hold?

The conversation around perimenopause is likely to continue evolving. Increased awareness is undoubtedly positive, but it’s crucial to approach this topic with nuance and critical thinking. Future trends may include:

  • More Personalized Treatment: A shift towards individualized care plans based on a woman’s specific symptoms and health history, rather than a one-size-fits-all approach.
  • Greater Emphasis on Lifestyle Interventions: Increased focus on diet, exercise, stress management, and sleep hygiene as foundational elements of midlife health.
  • Improved Diagnostic Tools: Development of more accurate and reliable methods for identifying and assessing perimenopausal symptoms.
  • Increased Scrutiny of the Industry: Greater transparency and accountability from companies marketing products and services related to perimenopause.

FAQ

Q: What exactly is perimenopause?
A: Perimenopause is the transitional period leading up to menopause, characterized by fluctuating hormone levels and potentially a range of symptoms.

Q: Is perimenopause a disease?
A: No, perimenopause is a natural biological process, not a disease.

Q: Should I seek medical help for perimenopause symptoms?
A: If your symptoms are significantly impacting your quality of life, it’s wise to consult a healthcare professional.

Q: Are hormone therapies always necessary?
A: Hormone therapies can be helpful for some women, but they also carry risks and are not appropriate for everyone. Discuss the potential benefits and risks with your doctor.

Did you know? Only 15% of women receive evidence-based interventions for menopause symptoms.

Pro Tip: Keep a detailed symptom journal to share with your doctor. This can help them accurately assess your situation and recommend the most appropriate course of action.

What are your thoughts on the increasing medicalization of perimenopause? Share your experiences and opinions in the comments below!

March 26, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Trial introduced to diagnose breast cancer earlier

by Chief Editor March 26, 2026
written by Chief Editor

Cutting Out the Middleman: New Trial Offers Direct Breast Cancer Screening Access

A new pilot program in Cambridgeshire is set to revolutionize breast cancer screening, allowing patients with concerning symptoms to bypass their GP and directly access diagnostic clinics. The trial, running across Addenbrooke’s, Hinchingbrooke, and Peterborough City hospitals, aims to accelerate diagnoses and alleviate pressure on already strained primary care services.

How Does Self-Referral Work?

Individuals experiencing worrying breast cancer symptoms can now self-refer through NHS 111 online or the NHS app. This streamlined process eliminates the initial step of a GP appointment, potentially shaving valuable time off the diagnostic pathway. Those who meet specific criteria will be offered a direct appointment at one of the three participating hospitals. Individuals who don’t meet the criteria will receive advice and guidance on alternative care options.

The Expertise Behind the Initiative

Dr. James Tanner, Consultant Radiologist at Cambridge University Hospitals and Clinical Director for Imaging, champions the new service. He believes it will significantly improve patient outcomes. “The self-referral service enables us to either rule out cancer for the vast majority of patients or provide an earlier diagnosis, which gives the best possibility of successful treatment,” Dr. Tanner stated. He also highlighted the positive impact on patients experiencing the stress and anxiety associated with potential cancer symptoms.

Easing the Burden on GPs and Boosting Early Detection

Currently, around 400 patients per week are referred to specialist breast services through their GPs. Of these, approximately 5% receive a breast cancer diagnosis. By enabling self-referral, the trial hopes to expedite this process, leading to earlier intervention and potentially improved survival rates. The initiative also addresses the growing demands on GP appointments, freeing up valuable time for other patient needs.

The Future of Cancer Screening: A National Trend?

This Cambridgeshire trial represents a potential shift in how cancer screening is approached nationally. Whereas self-referral isn’t yet widespread, the pressures on primary care and the proven benefits of early detection are driving interest in similar models. The success of this pilot could pave the way for broader implementation across the NHS.

Technological Integration and AI’s Role

The use of NHS 111 online and the NHS app for self-referral demonstrates the increasing integration of technology in healthcare. Looking ahead, artificial intelligence (AI) could play an even larger role in triaging symptoms and prioritizing referrals. AI-powered tools are already being developed to analyze medical images and identify potential anomalies, assisting radiologists in making faster and more accurate diagnoses.

Personalized Screening and Risk Assessment

Beyond self-referral, the future of cancer screening is likely to involve more personalized approaches. Advances in genomics and risk assessment tools will allow healthcare providers to identify individuals at higher risk of developing breast cancer and tailor screening schedules accordingly. This targeted approach could maximize the effectiveness of screening programs while minimizing unnecessary interventions.

Frequently Asked Questions

  • Who can use the self-referral service? Patients with worrying breast cancer symptoms who meet specific criteria.
  • How do I self-refer? Through NHS 111 online or the NHS app.
  • Where will I be referred to? Addenbrooke’s, Hinchingbrooke, or Peterborough City hospitals.
  • What if I don’t meet the criteria? You will receive advice and guidance on alternative services.

Pro Tip: If you notice any changes in your breasts, such as a new lump or changes in size or shape, don’t hesitate to seek medical advice. Early detection is key to successful treatment.

Stay informed about health news and updates. Explore more articles on cancer prevention and early detection here.

March 26, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

Families want transparency after Kula Hospital moves patients following storm damage

by Chief Editor March 25, 2026
written by Chief Editor

Kula Hospital’s Challenges Highlight Growing Risks to Rural Healthcare Infrastructure

The recent relocation of patients from Kula Hospital on Maui following severe storm damage underscores a critical vulnerability facing rural healthcare facilities across the United States: aging infrastructure and increasing climate-related disasters. The 116-year-old hospital, a historic landmark in Hawaiian healthcare, sustained significant water intrusion and flooding, forcing the temporary displacement of approximately 114 patients.

The Impact of Kona Low Storms and a Request for Federal Aid

Governor Josh Green has formally requested a Presidential Disaster Declaration from President Donald Trump to secure federal funding for repairs and recovery efforts. This request follows back-to-back Kona low storms that caused widespread damage across multiple Hawaiian islands. The storms have not only impacted Kula Hospital but have likewise strained emergency response capabilities statewide, with initial damage estimates exceeding $400 million and potentially surpassing $1 billion when combined.

More Than Just a Hospital: The Importance of Hale Makamae

The disruption extends beyond general medical care. Kula Hospital is also home to Hale Makamae, a unique nine-bed intermediate care facility for individuals with intellectual disabilities – the only licensed facility of its kind in Hawaii. The relocation of residents like Kelly Kaho’ohanohano to a facility on Oahu has understandably caused distress among families, who express concerns about a lack of clear communication and transparency from hospital officials.

Transparency Concerns and the Patient Experience

Moana Kaho’ohanohano, Kelly’s sister, voiced a common sentiment among families: a need for more information regarding the timeline for returning loved ones home. This highlights the emotional toll disasters accept on patients and their families, and the importance of proactive communication during times of crisis. Lynn Fulton, CEO of Maui Health, acknowledged the challenges, stating that the past two weeks have been incredibly demanding as they work to secure suitable locations and address the myriad of issues arising from the damage.

A Growing Trend: Climate Change and Healthcare Facilities

Kula Hospital’s situation isn’t isolated. Across the country, rural hospitals are grappling with aging infrastructure, limited resources, and increasing exposure to extreme weather events. The recent storms in Hawaii, which brought record rainfall and flooding, are indicative of a broader trend: climate change is exacerbating existing vulnerabilities in healthcare systems. FEMA has been brought in early to conduct damage assessments, recognizing the scale of the challenge.

The Financial Burden of Resilience

Strengthening infrastructure to withstand future disasters requires significant investment. Governor Green is hoping for federal assistance to cover up to 90% of recovery costs, including debris removal, emergency protective measures, and permanent repairs. Still, proactive measures – such as flood mitigation, improved drainage systems, and resilient building materials – are crucial to minimizing future damage and ensuring continuity of care.

Looking Ahead: Mobile Units and Long-Term Solutions

Maui Health is exploring the use of mobile units to provide continued services at the Kula Hospital site while repairs are underway. CEO Fulton emphasized that the goal is not to abandon the facility but to preserve services for the Upcountry community. This commitment is vital, as the loss of a local hospital can have devastating consequences for rural communities, limiting access to essential healthcare services.

FAQ

Q: What caused the damage to Kula Hospital?
A: The hospital sustained significant water intrusion, flooding, and infrastructure damage due to back-to-back Kona low storms.

Q: Where were the patients relocated?
A: Patients were relocated to Maui Memorial Medical Center in Wailuku, Hale Makua in Kahului, an empty facility in Kihei, and facilities on Oahu.

Q: What is Hale Makamae?
A: Hale Makamae is a nine-bed intermediate care facility within Kula Hospital for individuals with intellectual disabilities, and it is the only licensed facility of its kind in Hawaii.

Q: Has a disaster declaration been issued?
A: Governor Josh Green has requested a Presidential Disaster Declaration from President Donald Trump, but it has not yet been approved.

Q: What is being done to repair Kula Hospital?
A: Hospital officials are working to repair the damage and are exploring the use of mobile units to continue providing services.

Did you know? Kula Hospital is recognized as a historic site due to its significance in the history of healthcare in Hawaii.

Pro Tip: Families with loved ones in affected facilities should proactively seek information from hospital officials and advocate for clear communication regarding relocation plans and timelines.

We encourage you to share your thoughts and experiences in the comments below. For more information on disaster preparedness and healthcare resilience, explore our articles on rural healthcare challenges and climate change impacts.

March 25, 2026 0 comments
0 FacebookTwitterPinterestEmail
Health

COVID-19 Deaths in US Significantly Undercounted, Study Finds

by Chief Editor March 19, 2026
written by Chief Editor

The Uncounted Toll: How COVID-19’s Hidden Deaths Reveal Systemic Flaws

New research suggests the official U.S. COVID-19 death toll significantly underestimated the pandemic’s true impact, with as many as 155,000 additional deaths likely going uncounted in 2020, and 2021. This isn’t simply a matter of statistical correction; it exposes deep-seated disparities in healthcare access and the limitations of our death investigation systems.

Disparities in Diagnosis and Reporting

The study, published in Science Advances, highlights that those most likely to have their COVID-19 deaths go unrecorded were Hispanic individuals and other people of color, particularly in the early months of the pandemic and in states across the South and Southwest – including Alabama, Oklahoma, and South Carolina. This discrepancy stems from several factors. Early in the pandemic, access to testing was limited, especially outside of hospital settings. Many individuals who fell ill and died at home weren’t tested, and therefore COVID-19 wasn’t listed on their death certificates.

the quality of death investigations varies significantly across the country. Some areas rely on elected coroners who may lack the specialized training of medical examiners, potentially leading to less accurate determinations of cause of death. Research suggests that even partisan opinions may have influenced testing and reporting.

Beyond Direct COVID-19 Deaths: The Ripple Effect

While this research focuses on deaths *from* COVID-19 infection, it’s crucial to remember the broader impact of the pandemic. The pandemic also led to increased deaths from other causes as people were unable to access routine medical care or experienced worsening conditions due to overwhelmed healthcare systems. For example, individuals with pre-existing conditions may have died because they couldn’t receive timely treatment.

The Role of Artificial Intelligence in Uncovering Hidden Data

Researchers utilized machine learning to analyze death certificate data, comparing patterns from hospital deaths (where COVID-19 testing was routine) to deaths occurring outside of hospitals. This allowed them to identify cases where deaths likely attributable to COVID-19 were instead categorized under conditions like pneumonia or diabetes. Scientists are still evaluating the strengths and weaknesses of this approach, but the results are considered “intriguing.”

The Ongoing Impact and Future Preparedness

Even after the acute phase of the pandemic, excess deaths – the number of deaths above what would normally be expected – continue to rise in the U.S. This suggests that the pandemic’s long-term consequences are still unfolding. Steven Woolf, a researcher at Virginia Commonwealth University, emphasizes that marginalized communities continue to experience disproportionately high mortality rates due to limited access to care.

Addressing these issues requires a multi-faceted approach. Strengthening public health infrastructure, improving access to affordable healthcare, and standardizing death investigation practices are all critical steps. Investing in more robust data collection and analysis systems, including the employ of advanced technologies like machine learning, can help us better understand and respond to future public health crises.

Pro Tip: Understanding excess deaths provides a broader picture of a pandemic’s impact than simply looking at confirmed COVID-19 deaths. It captures the indirect consequences of the crisis on the healthcare system and overall population health.

FAQ

How many COVID-19 deaths have been reported in the U.S.?

The CDC reports more than 1.2 million COVID-19 deaths since the start of the pandemic in early 2020.

What is “excess death”?

Excess death refers to the number of deaths above what would normally be expected based on historical data. It can indicate the direct and indirect impacts of a crisis like a pandemic.

Why were some COVID-19 deaths not counted?

Limited access to testing, particularly early in the pandemic and outside of hospitals, contributed to many deaths going uncounted. Variations in death investigation practices also played a role.

Learn More: Explore the CDC’s COVID-19 data and read the original research published in Science Advances.

What are your thoughts on the accuracy of reported COVID-19 deaths? Share your perspective in the comments below!

March 19, 2026 0 comments
0 FacebookTwitterPinterestEmail
Newer Posts
Older Posts

Recent Posts

  • Tokyo Researchers Control Inkjet Printing Coffee Ring Effect with Nanobubbles

    July 11, 2026
  • Noskova claims Wimbledon title in dramatic all-Czech final

    July 11, 2026
  • US Demands Iran End Attacks on Ships in Strait of Hormuz

    July 11, 2026
  • WWF Boosts £1m for Wildlife Conservation Amid Ethical Debates

    July 11, 2026
  • Harvard Astrophysicist Avi Loeb Leads White House UAP Science Council

    July 11, 2026

Popular Posts

  • 1

    Maya Jama flaunts her taut midriff in a white crop top and denim jeans during holiday as she shares New York pub crawl story

    April 5, 2025
  • 2

    Saar-Unternehmen hoffen auf tiefgreifende Reformen

    March 26, 2025
  • 3

    Marta Daddato: vita e racconti tra YouTube e podcast

    April 7, 2025
  • 4

    Unlocking Success: Why the FPÖ Could Outperform Projections and Transform Austria’s Political Landscape

    April 26, 2025
  • 5

    Mecimapro Apologizes for DAY6 Concert Chaos: Understanding the Controversy

    May 6, 2025

Follow Me

Follow Me
  • Cookie Policy
  • CORRECTIONS POLICY
  • PRIVACY POLICY
  • TERMS OF SERVICE

© 2026 Newsy Today. All rights reserved.
For contact, advertising, copyright, issues email: [email protected]


Back To Top

For contact, advertising, copyright, issues email: [email protected]

Newsy Today
  • Business
  • Entertainment
  • Health
  • News
  • Sport
  • Tech
  • World